Pharmacodynamic model of the dynamic response of Pseudomonas aeruginosa biofilms to drug treatments
暂无分享,去创建一个
[1] Vassily Hatzimanikatis,et al. Spatio-temporal modeling of the crowding conditions and metabolic variability in microbial communities , 2021, PLoS Comput. Biol..
[2] L. Villarreal-Treviño,et al. Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico. , 2021, Enfermedades infecciosas y microbiologia clinica.
[3] M. Windbergs,et al. Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems , 2021, Drug Delivery and Translational Research.
[4] M. Ntzouni,et al. Colistin Dependence in Extensively Drug-Resistant Acinetobacter baumannii Strain Is Associated with ISAjo2 and ISAba13 Insertions and Multiple Cellular Responses , 2021, International journal of molecular sciences.
[5] Minh Tam Tran Thi,et al. Pseudomonas aeruginosa Biofilms , 2020, International journal of molecular sciences.
[6] P. Stewart,et al. Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology , 2019, Journal of bacteriology.
[7] Andrey G. Cherstvy,et al. Burst statistics in an early biofilm quorum sensing model: the role of spatial colony-growth heterogeneity , 2019, Scientific Reports.
[8] Christel A. S. Bergström,et al. Model-Based Drug Development in Pulmonary Delivery: Pharmacokinetic Analysis of Novel Drug Candidates for Treatment of Pseudomonas aeruginosa Lung Infection , 2019, Journal of pharmaceutical sciences.
[9] Mathias Müsken,et al. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosa , 2018, Antimicrobial Agents and Chemotherapy.
[10] Robert Tyminski. Breaking it , 2018, Male Alienation at the Crossroads of Identity, Culture and Cyberspace.
[11] L. Frunzo,et al. Continuum and discrete approach in modeling biofilm development and structure: a review , 2018, Journal of mathematical biology.
[12] S. Rice,et al. Mesoscopic Energy Minimization Drives Pseudomonas aeruginosa Biofilm Morphologies and Consequent Stratification of Antibiotic Activity Based on Cell Metabolism , 2018, Antimicrobial Agents and Chemotherapy.
[13] R. Gehring,et al. Limitations of MIC as sole metric of pharmacodynamic response across the range of antimicrobial susceptibilities within a single bacterial species , 2016, Scientific Reports.
[14] P. Stewart,et al. Reaction–diffusion theory explains hypoxia and heterogeneous growth within microbial biofilms associated with chronic infections , 2016, npj Biofilms and Microbiomes.
[15] Yue Zheng,et al. Biofilm formation mechanisms and targets for developing antibiofilm agents. , 2015, Future medicinal chemistry.
[16] S. Britland,et al. Strategies for antimicrobial drug delivery to biofilm. , 2014, Current pharmaceutical design.
[17] I. Banat,et al. Microbial biofilms: biosurfactants as antibiofilm agents , 2014, Applied Microbiology and Biotechnology.
[18] J. Knobloch,et al. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer. , 2014, International journal of antimicrobial agents.
[19] D. Thornton,et al. Cystic fibrosis: an inherited disease affecting mucin-producing organs. , 2014, The international journal of biochemistry & cell biology.
[20] N. Cogan,et al. Effect of Periodic Disinfection on Persisters in a One-Dimensional Biofilm Model , 2013, Bulletin of mathematical biology.
[21] I. Rajman. PK/PD modelling and simulations: utility in drug development. , 2008, Drug discovery today.
[22] B. Ploeger,et al. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. , 2008, Trends in pharmacological sciences.
[23] Philip S. Stewart,et al. Modeling Antibiotic Tolerance in Biofilms by Accounting for Nutrient Limitation , 2004, Antimicrobial Agents and Chemotherapy.
[24] Philip S. Stewart,et al. Diffusion in Biofilms , 2003, Journal of bacteriology.
[25] R. Donlan,et al. Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.
[26] P. Stewart,et al. Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms , 1994, Antimicrobial Agents and Chemotherapy.
[27] P. Stewart,et al. A model of biofilm detachment , 1993, Biotechnology and bioengineering.
[28] Nichols,et al. Inhibition of tobramycin diffusion by binding to alginate , 1988, Antimicrobial Agents and Chemotherapy.